MktsMarkets

West Pharmaceutical Services, Inc.
NYSE: WSTKey statistics
WST News
Stories mentioning WST from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 844,900 | 805,000 | 804,600 | 766,500 | 698,000 | 748,800 | 746,900 | 702,100 |
| Cost of Goods Sold | 548,500 | 501,100 | 510,300 | 492,600 | 466,100 | 475,200 | 482,200 | 472,100 |
| Gross Profit | 296,400 | 303,900 | 294,300 | 273,900 | 231,900 | 273,600 | 264,700 | 230,000 |
| Operating Expenses | ||||||||
| Research & Development | 15,800 | 21,800 | 17,100 | 19,100 | 16,300 | 18,500 | 15,500 | 17,500 |
| Sales General & Admin | 99,500 | 107,000 | 102,700 | 95,900 | 88,000 | 85,300 | 83,500 | 83,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 177,100 | 156,600 | 167,600 | 153,700 | 107,000 | 159,600 | 161,300 | 126,200 |
| Interest Income | ||||||||
| Interest Expense | 700.00 | |||||||
| Other Expense | (200.00) | (400.00) | (200.00) | (200.00) | (200.00) | (300.00) | (700.00) | 0.00 |
| Pretax Income | 180,100 | 161,500 | 171,900 | 157,000 | 110,500 | 164,900 | 164,500 | 128,700 |
| Tax Provision | 44,700 | 33,300 | 34,000 | 30,200 | 24,100 | 36,800 | 32,400 | 21,900 |
| Net Income (Loss) | 138,800 | 132,100 | 140,000 | 131,800 | 89,800 | 130,100 | 136,000 | 111,300 |
| Earnings Per Share (Basic) | 1.93 | 1.83 | 1.94 | 1.82 | 1.24 | 1.78 | 1.87 | 1.52 |
| Earnings Per Share (Diluted) | 1.92 | 1.82 | 1.92 | 1.82 | 1.23 | 1.77 | 1.85 | 1.51 |
| Weighted Average Shares Outstanding (Basic) | 72,000 | 72,300 | 72,200 | 72,200 | 72,500 | 73,000 | 72,800 | 73,000 |
| Weighted Average Shares Outstanding (Diluted) | 72,400 | 72,700 | 72,600 | 72,500 | 73,000 | 73,700 | 73,400 | 73,700 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About WST
West Pharmaceutical Services, Inc. (NYSE: WST) is a stock listed on the New York Stock Exchange under the ticker symbol WST. It last traded at $392.34 (Nov 20, 2026, 9:30 AM ET), down 1.1% on the day. That gives West Pharmaceutical Services a market capitalisation of $28.3B and a price-to-earnings ratio of 44.3.
Over the past 52 weeks WST has traded between $223.83 and $438.27.
Revenue for the quarter ended Mar 31, 2026 was $844.9M; net income $138.8M. Revenue was up 21.0% from $698.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $844.9M | $138.8M | 16.4% |
| Dec 31, 2025 | $805.0M | $132.1M | 16.4% |
| Sep 30, 2025 | $804.6M | $140.0M | 17.4% |
| Jun 30, 2025 | $766.5M | $131.8M | 17.2% |
From West Pharmaceutical Services’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…